TrialStat®, a technology arm of Jubilant Clinsys and its parent company, Jubilant Life Sciences, is a leading provider of on-demand EDC solutions which empower clinical research professionals to collect and manage clinical data nearly twice as fast as the industry average using innovative, easy-to-use, configurable and flexible features through a secure browser interface.
About Jubilant Clinsys
Jubilant Clinsys is a scientifically focused, global, contract research organization that provides pharmaceutical, biotechnology and medical device companies with a full range of services in support of Phase 1 - IV drug and device development. Founded in 1992, the company is a subsidiary of Jubilant Life Sciences and a fully integrated partner with Jubilant Biosys and Jubilant Chemsys. Jubilant Clinsys offers a full range of clinical research services for both standalone and integrated projects:
- Clinical Operations
- Clinical Pharmacology and Pathology
- Data Management
- Medical Affairs
- Medical Writing
- Quality Assurance
- Regulatory Services
- TrialStat-ORBIT -EDC Solution
About Jubilant Life Sciences
Jubilant Life Sciences Limited, an integrated pharmaceutical and life sciences company, is the largest Custom Research and Manufacturing Services (CRAMS) player and a leading Drug Discovery and Development Solution (DDDS) provider out of India. Recently it has been ranked at No. 6 position amongst the Top 10 Global contract manufacturing and services outsourcing players of the pharmaceutical industry. The Company provides Life Science Products and Services across the value chain, serving its customers globally with its ground presence in India, North America, Europe and China. The Company is well recognized as a 'Partner of Choice' by leading life sciences companies worldwide.
On November 17, 2008, Jubilant Life Sciences, formerly Jubilant Organosys Ltd., announced that its subsidiary, Jubilant Clinsys, a global contract research organization (CRO), had acquired the EDC product developed by TrialStat®, a Canadian-based company.
This product, now branded as TrialStat-ORBIT, is a Web-based electronic data capture (EDC) solution used by a wide range of pharmaceutical and CRO customers worldwide. ORBIT was the industry's first EDC platform to allow all aspects of a study to be configured, deployed and managed through a browser interface, enabling customers to start their studies quickly and cost-effectively.
Jubilant Clinsys' extensive global resources will enable TrialStat to continue its proven record of growth, customer service and product innovation. This agreement gave TrialStat's existing CRO and biopharmaceutical customer base a broader scope of services.
Jubilant Life Sciences had identified this product as one of the most innovative EDC solutions on the market and was determined to include it in its offerings to its customers globally.
Commenting on the acquisition, Mr. Shyam S. Bhartia, Chairman and Managing Director and Mr. Hari S. Bhartia, Co-Chairman and Managing Director, Jubilant Life Sciences, said "The addition of the TrialStat® [EDC product] and its proven EDC offering will allow Jubilant Clinsys to continue to expand its integrated solutions for pharmaceutical, biotechnology and medical device organizations. This acquisition is an excellent fit and addresses the industry's continuously evolving requirements in EDC."